Medy-Tox Inc. Logo

Medy-Tox Inc.

Develops and markets botulinum toxins and dermal fillers for global aesthetic & therapeutic use.

086900 | KO

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
South Korea
Address:
충청북도 청원군 오창읍 각리1길 78 (주)메디톡스, 청원군
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Medy-Tox Inc. is a global biopharmaceutical company focused on the research, development, and commercialization of aesthetic and therapeutic products. The company's core portfolio consists of botulinum toxin preparations, including its flagship brands Neuronox®, INNOTOX®, and Coretox®, and a range of hyaluronic acid dermal fillers, such as Neuramis®. A pioneer in the South Korean market, Medy-Tox has established a significant presence in the global botulinum toxin industry, distinguished by its robust R&D pipeline and the development of multiple unique formulations. The company also produces a dermocosmetic line under the NEURADERM brand and operates an extensive global network to market its products worldwide.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Medy-Tox Inc. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-09-10 00:00
Notice of Dividend Amount
중간(분기)배당을위한주주명부폐쇄(기준일)결정
Korean 5.3 KB
2025-08-26 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 25.5 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 2.7 MB
2025-08-11 00:00
Earnings Release
연결재무제표기준영업(잠정)실적(공정공시)
Korean 16.4 KB

Automate Your Workflow. Get a real-time feed of all Medy-Tox Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Medy-Tox Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Zealand Pharma Logo
Developing innovative peptide medicines for metabolic and inflammatory diseases.
Denmark ZEAL
Zelluna ASA Logo
Developing off-the-shelf TCR-NK cell therapies to treat patients with solid cancers.
Norway ULTI
Zentiva 2 Logo
European provider of high-quality, affordable generic and over-the-counter medicines.
Slovakia SKF
Zentiva S.A. Logo
Develops and distributes affordable generic, OTC, and specialty medicines across Europe.
Romania SCD
ZERIA PHARMCEUTICAL CO., LTD. Logo
Develops and distributes prescription & consumer healthcare products in Europe and Asia.
Japan 4559
株式会社PRISM BioLab Logo
A biotech creating novel drugs by targeting previously "undruggable" protein interactions.
Japan 206A

Talk to a Data Expert

Have a question? We'll get back to you promptly.